ILMN is tries to outbid their largest customer, BGI, on aquiring GNOM. ILMN bid gets turned down and now they are trying to appeal an unsuccesful patent suit against GNOM. How could anyone like a company that is as vindictive as ILMN. A bonehead move like trying to outbid your largest customer and then throwing good money after bad on appealing the decision of an unsuccesful patent suit proves to be a very questionable way of doing business. I used to hold ILMN in high regard but after this latest course of actions ILMN has shown itself to be a real loser.
So if you were running ILMN, you would just sit back and allow your biggest customer to potentially become one of your biggest direct competitors? Serious question here, I really want to understand your point of view.
We are talking about a small part of Illumina's business (genotype service). GNOM does not make and market instruments (the lions share of ILMN's business). ILMN had plenty of time to express interest before BGI stepped in. Had they made an offer, early on, that would have been smart business. Making an offer after failing in the patent suit and after BGI put in a tender shows ILMN to be vindictive and hostile. BGI will squash ILMN regardless of how this deal ends up going. With the ILMN play BGI will, undoubtably, be more motivated to take ILMN out.